The combination treatment induced increased apoptotic patient MM cell death, evidenced by the abundance of cleaved-CAS3/7 levels and by Annexin-V/7-AAD (Fig. 6A3, 7B). This evidence concerns the gene ANXA5 and Miyoshi myopathy.